Differentiated Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-05-22Clinical Trial Update: Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer [Phase 3]
Phase 3 trial evaluating dabrafenib plus trametinib in previously treated metastatic radioactive iodine-refractory BRAF V600E-positive diffe…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
This clinical trial update reports completion of a study evaluating a thyroglobulin point-of-care assay for rapid detection of metastatic di…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors [Phase 1]
Pfizer is conducting a Phase 1 study of PF-07799544 as a monotherapy or in combination for advanced solid tumors, including melanoma and gli…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating whole-body 124I-PET/CT dosimetry in patients with differentiated thyroid cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Pembrolizumab in High-risk Thyroid Cancer [Phase 2]
Phase 2 clinical trial update for pembrolizumab in high-risk differentiated thyroid cancer; study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Decision Aid Efficacy in Low Risk Thyroid Cancer [NA]
This document provides an update on a clinical trial evaluating a decision aid for patients with low-risk thyroid cancer; the study is not y…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) [Phase 2]
Phase 2 trial update for selpercatinib in RET fusion differentiated thyroid cancer is currently recruiting (RAISE trial).
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. [Phase 2]
A Phase 2 trial update for cabozantinib in advanced radioactive-iodine refractory differentiated thyroid cancer; the study is currently acti…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer [Phase 2]
A Phase 2 trial evaluating the combination of MEK inhibitor trametinib and BRAF V600E inhibitor dabrafenib with radioactive iodine in patien…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC) [Phase 2]
This is a Phase 2 trial comparing lenvatinib 24 mg/day versus 10 mg/day in patients with radioactive iodine–resistant differentiated thyroid…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer [Phase 4]
Phase 4 study evaluating the safety and efficacy of Lenvatinib in patients with refractory differentiated thyroid cancer has completed. The …
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer [Phase 3]
Phase 3 trial evaluating whether prophylactic central neck dissection can modify outcomes in low-risk differentiated thyroid cancer; the stu…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Empirical Radioactive Iodine Therapy in DTC [Phase 1, Phase 2]
Clinical trial update for empirical radioactive iodine therapy in differentiated thyroid cancer, spanning Phase 1 and Phase 2, not yet recru…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers [NA]
University College London is conducting a trial comparing hemithyroidectomy and total thyroidectomy for low-risk differentiated thyroid canc…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Lenvatinib in Locally Advanced Invasive Thyroid Cancer [Phase 2]
Phase 2 clinical trial of lenvatinib for locally advanced invasive thyroid cancer is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Anlotinib and Benmelstobart in DTC [Phase 2]
A Phase 2 clinical trial evaluating the combination of Anlotinib and Benmelstobart for differentiated thyroid cancer is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer [NA]
A clinical trial sponsored by Ankara University is evaluating F-18 tetrafluoroborate PET/CT imaging for differentiated thyroid cancer and is…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
A Mayo Clinic-sponsored clinical study is evaluating the 18F-TFB PET/CT scan for imaging differentiated thyroid cancers; the trial is curren…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy [NA]
A prospective study evaluating the safety and efficacy of radiofrequency ablation for metastatic lymph nodes in differentiated thyroid cance…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
A clinical trial evaluating thyroid hormone replacement after radioactive iodine therapy to determine its value and efficacy for differentia…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Iodine Uptake After a Low Iodine Diet [NA]
The document reports on a clinical study assessing iodine uptake after a low iodine diet in differentiated thyroid cancer. The trial is curr…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: IDEntification of New Predisposition Genes in Differentiated THYroid Cancer [NA]
A Nantes University Hospital–led study to identify predisposition genes in differentiated thyroid cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients [NA]
A clinical trial is testing a web-based program to help differentiated thyroid cancer patients manage radioactive iodine–related symptoms an…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer [Phase 1]
A Phase I study of Af-001 for differentiated thyroid cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical evaluations of AL2846 Capsule for differentiated thyroid cancer have been completed. The study was sponsored by…